Abstract
Human apurinic/apyrimidinic (AP) endonuclease 1 (APE1) is an essential DNA repair enzyme which uses a single active site to process DNA damage via two distinct activities: (1) AP-endonuclease and (2) 3′ to 5′ exonuclease. The AP-endonuclease activity cleaves at AP-sites, while the exonuclease activity excises bulkier 3′ mismatches and DNA damage to generate clean DNA ends suitable for downstream repair. Molecular details of the exonuclease reaction and how one active site can accommodate various toxic DNA repair intermediates remains elusive despite being biologically important. Here, we report multiple high-resolution APE1–DNA structural snapshots revealing how APE1 removes 3′ mismatches and DNA damage by placing the 3′ group within the intra-helical DNA cavity via a non-base flipping mechanism. This process is facilitated by a DNA nick, instability of a mismatched/damaged base, and bending of the DNA. These results illustrate how APE1 cleanses DNA dirty-ends to generate suitable substrates for downstream repair enzymes.
The essential DNA repair enzyme apurinic/apyrimidinic endonuclease 1 (APE1) has both endonuclease and exonuclease activities. Here, the authors present DNA bound human APE1 crystal structures which give insights into its exonuclease mechanism.
Introduction
Nucleobase structures and base-pairing properties are altered by DNA damage, potentially leading to genomic mutations. Consequently, DNA damage is a major source of the mutation load that gives rise to numerous human maladies. To maintain genomic integrity, base excision repair (BER) is tasked with removing and replacing DNA lesions generated by oxidation and spontaneous base loss1. The BER pathway (Fig. 1a) is comprised of several factors; the scaffolding protein XRCC1, a damage-specific DNA glycosylase to remove the damaged base, apurinic/apyrimidinic endonuclease (APE1) to cleave the DNA backbone 5′ of the resulting apurinic/apyrimidinic (AP) site, DNA polymerase (pol) β to synthesize the DNA, and DNA ligase III to seal the repaired DNA. Gap filling synthesis by pol β requires a 3′-OH, necessitating removal of DNA damage at the 3′ end prior to repair. This cleaning of 3′ “dirty ends” can be performed by APE12–4. Additionally, proper BER requires pol β to choose the correct nucleotide during DNA synthesis. Because pol β has only moderate fidelity compared to the replicative pols δ and ε, and lacks a proofreading domain, misinsertions during BER can occur and must be removed by a surrogate enzyme(s) in order to avoid genomic mutations5,6. APE1 has been proposed to serve this vital proofreading role during BER because of its established protein-protein interactions with pol β and ability to remove 3′ mismatches2,7,8. These additional activities of APE1 result in a modified version of the BER cycle in which APE1 can perform multiple functions (Fig. 1a, blue arrow).
Two predominant APE1 DNA cleavage reactions are (1) AP-endonuclease (AP-endo) and (2) exonuclease (exo) (Fig. 1b). Biochemical studies have shown that the AP-endo activity is more efficient in vitro, and the role of the exo activity has remained poorly understood in comparison9. Structural characterization of the APE1 AP-endo reaction demonstrated that the AP-site is flipped out of the DNA helical cavity and into the active site, allowing for phosphodiester bond cleavage to occur via a single metal ion and nucleophilic water10,11. APE1 exo activity removes 3′ end groups, including oxidatively damaged DNA bases, chain terminating nucleotide analog drugs, terminal blocking groups, and mismatched bases2–4,12,13. Despite the important biological implications of the exo activity, key mechanistic features of the exo reaction remain elusive. One major enigma is how the active site can form compactly around a baseless AP-site, but also accommodate the diversity of known exo substrates, including mismatched and modified bases11. To address this, we first utilized a mismatched nicked DNA substrate, representing a BER intermediate generated after incorrect nucleotide insertion by pol β (Fig. 1a), to structurally and kinetically characterize the APE1 exo mechanism. This study was expanded further to examine the cleansing of DNA dirty ends that arise during oxidative stress and would be blocks to subsequent replication and repair. These structures provide insight into how one active site can accommodate both AP-DNA and multiple exo substrates utilizing two different types of DNA backbone cleavage.
Results
APE1 bound to a mismatched DNA exonuclease substrate
We obtained a structure of APE1 engaged with a double stranded DNA substrate which contains a C/T mismatch at the 3′ end and a phosphate at the 5′ end of a nick. This substrate represents a BER intermediate in which pol β has misinserted a cytosine (C) across from a templating thymine (T) (Fig. 1a, blue arrow). A C/T mismatch was chosen because observations in our lab, as well as data published by others, indicate it as an optimal substrate for APE1 exo activity14–17. Initial substrate complex crystals were generated in a solution containing CaCl2, which inhibits catalysis18,19, and resulted in clear electron density for the phosphate and sugar moiety. However, relatively poor density was observed for the base of the mismatched C. To confirm we obtained an uncut substrate complex, we used otherwise identical DNA with a phosphorothioate (PS) modification 5′ to the mismatched C. This modification substitutes sulfur for a non-bridging oxygen, preventing incision11,20,21. The resulting substrate complex diffracted to 2.10 Å (Table 1). Of note, density for the mismatched C in both the PS and CaCl2 generated substrate complexes is similar, confirming that crystals grown in CaCl2 are substrate complexes.
Table 1.
3′ Mismatch | 3′ Mismatch (MnCl2) | 3′ Mismatch (product) | 3′ Match | 3′ PG | 3′ Mismatch (F266A) | |
---|---|---|---|---|---|---|
Data collection | ||||||
Space group | P21 | P21 | P21 | P1 | P21 | P21 |
Cell dimensions | ||||||
a, b, c (Å) | 71.3, 63.8, 90.9 | 71.5, 64.4, 91.5 | 71.9, 63.5, 90.5 | 44.3, 61.9, 73.8 | 71.4,64.3,91.1 | 71.1, 65.5, 91.4 |
α, β, γ (°) | 90, 109.7, 90 | 90, 109.9, 90 | 90, 109.4, 90 | 82.6, 76.9, 85.9 | 90, 110.1, 90 | 90, 110.1, 90 |
Resolution (Å) | 25–2.10 | 25–2.20 | 25–2.3 | 25–2.6 | 25–2.3 | 25–2.0 |
Rmeasa(%) | 10.6 (85.1) | 9.4 (>100%) | 12.4 (93.9) | 14.6 (67.6) | 10.5 (75.7) | 8.4 (>100%) |
I/σI | 13.7 (1.2) | 24.4 (1.1) | 15.3 (1.3) | 13.8 (2.0) | 15.6 (1.8) | 18.4 (1.4) |
cc1/2b | 0.692 | 0.644 | 0.757 | 0.771 | 0.775 | 0.758 |
Completenessa (%) | 95.1 (87.3) | 99.8 (98.6) | 99.4 (99.4) | 99.6 (98.5) | 99.8 (99.8) | 99.9 (99.9) |
Redundancya | 4.0 (2.9) | 11.2 (2.6) | 4.2 (2.5) | 4.0 (3.0) | 4.5 (2.5) | 5.0 (4.4) |
Refinement | ||||||
Resolution (Å) | 25–2.10 | 25–2.20 | 25–2.3 | 25–2.6 | 25–2.3 | 25–2.0 |
No. reflections | 71,157 | 74,864 | 58,422 | 43,970 | 64,984 | 53,376 |
Rwork/Rfree | 20.4/24.9 | 22.9/26.5 | 21.3/27.0 | 21.7/28.7 | 18.9/24.0 | 21.0/25.8 |
No. atoms | ||||||
Protein | 4380 | 4371 | 4354 | 4306 | 4389 | 4381 |
DNA | 955 | 917 | 834 | 834 | 871 | 955 |
Water | 183 | 163 | 166 | 77 | 243 | 244 |
B-factors (Å2) | ||||||
Protein | 46.5 | 49.1 | 44.9 | 43.1 | 33.0 | 36.4 |
DNA | 78.1 | 80.1 | 63.3 | 54.7 | 55.5 | 71.0 |
3′ Base/PG DNA | 52.4 | 62.2 | N/A | 37.1 | 35.9 | 47.9 |
Water | 46.7 | 47.8 | 45.1 | 37.8 | 35.2 | 39.5 |
R.m.s deviations | ||||||
Bond length (Å) | 0.009 | 0.011 | 0.010 | 0.012 | 0.008 | 0.011 |
Bond angles (°) | 1.065 | 1.256 | 1.161 | 1.440 | 1.126 | 1.298 |
PDB ID | 5WN4 | 5WN5 | 5WN1 | 5WN0 | 5WN2 | 5WN3 |
aHighest resolution shell is shown in parentheses.
bFor highest resolution shell
The APE1 exo substrate structure revealed the mismatched C is in position for removal by incision of the 5′-phosphate backbone opposite an “opposing” T base and a bend in the DNA (Fig. 1c, d). In this conformation the mismatched C is positioned out of the protein active site into the open intra-helical cavity and the 3′ end of the DNA nick and phosphate backbone shift up and into the protein active site for cleavage. This is in stark contrast to the APE1 AP-endo cleavage mechanism which flips the AP-site into the protein active site, away from the DNA helix, to orient the phosphate backbone for cleavage. The active site for APE1 AP-endo and exo are shown in Fig. 2a, b with the C1′ position of the nucleoside sugar indicated for orientation. The C1′ position for the mismatched C in the APE1 exo structure is shifted ~24° and is 1.4 Å from its position in the APE1 AP-endo complex. The mismatched base does not make any apparent contacts with the protein active site, but appears to be sterically restricted into the intra-helical position by F266 and W280 (Fig. 2a). The opening up of the intra-helical cavity in the APE1 exo substrate structure occurs via several perturbations, including a ~10° sharper bend in the conformation of the DNA (Fig. 1d), destabilization of residue R177 (B-factor 66.9 Å2 compared to 26.7 Å2), and M270 acting as a wedge to coordinate the opposing T away from the mismatched C (Fig. 2a). The 5′-phosphate is coordinated by W280 and N226, as well as the oxygen (O2) of the mismatched C (Fig. 2a). Both the nick in the DNA and the shifted positon of the phosphate at the 5′ end allows for the greater bend in the DNA and space for the mismatched base while keeping the phosphate backbone in positon for catalysis (Fig. 2c, d). The phosphate backbone oxygen (O5′) is coordinated to N174 (ND2) and N212 (OD1) (Fig. 3a). The 3′-OH of the sugar is also coordinated to N174, while Y171 and H309/E96 coordinate the non-bridging oxygen and sulfur, respectively. Importantly, a well-ordered water molecule is in position to act as the nucleophile (Fig. 3a, b). This water is coordinated by the non-bridging oxygen and sulfur atoms of the backbone phosphate, positioning the water oxygen atom 2.9 Å from the phosphorus atom (Fig. 3b). The oxygen atoms of N212 and D210 come within hydrogen bonding distance of the nucleophilic water molecule at 2.6 and 2.5 Å, respectively. Also observed is a hydrogen bonding network between E96, N68, D210, and N212 that likely alters the pKa of D210, thus facilitating the deprotonation of the water and subsequent nucleophilic attack at the phosphate backbone during cleavage. These contacts are consistent with a water mediated nucleophilic attack mechanism.
The APE1 exo reaction has been reported to be metal dependent, however our structures reported above lack a clearly identifiable metal ion, even in the presence of CaCl2. Identifying the number and binding site of metal ions for APE1 cleavage has been historically challenging11,22,23. To determine the metal binding site(s) used for the exo reaction, we briefly soaked PS substrate crystals of the APE1 exo complex in a cryosolution containing MnCl2 and determined a 2.20 Å substrate complex (Table 1). Using the anomalous signal from Mn2+, we determined the position of a single, catalytic metal coordinated by D308, D70, E96, and the phosphate backbone of the mismatched C (Fig. 3c). The location of the catalytic metal is identical to that in the APE1 AP-endo structure and is adjacent to the site of cleavage, poised to facilitate catalysis and stabilize reaction intermediates. All other contacts are identical to those observed in the metal free APE1 exo substrate complex, described above, including the nucleophilic water bound within the active site (Fig. 3).
APE1 exonuclease product and matched DNA substrate complexes
The APE1 exo activity can proofread pol β misinsertions to regenerate a 1-nt gapped DNA product, providing a second chance for correct (matched) pol β gap filling DNA synthesis (Fig. 1a)7,8. To obtain an APE1 exo product structure, we first grew an exo substrate complex crystal in the presence of CaCl2 and subsequently transferred it to a cryosolution containing MgCl2 to initiate catalysis. This approach relies on APE1 to perform backbone cleavage, excising the base, in crystallo. The resulting crystal was flash frozen after soaking for 2.5 h and diffracted to 2.3 Å (Table 1). This structure shows APE1 in complex with its single nucleotide gapped DNA product, revealing the mismatched base has been removed (Fig. 4a). Importantly, because this complex was generated in crystallo with an APE1 substrate crystal, it verifies that our substrate structures represent APE1 in the catalytically competent conformation for exo activity. The newly generated 3′-OH is stabilized by a hydrogen bonding network involving N212, D210, Y171, N174, H309, E96, N68, and three water molecules (Fig. 4a). The phosphate at the 5′ end of the nick is coordinated by N222, W280, and two waters. The product complex lacks a clearly identifiable metal ion within the active site, even with high concentrations of MgCl2 present in the soak. This is consistent with previous structural snapshots indicating high disorder for Mg2+ within the active site11,22,23.
APE1 exo activity removes 3′ mismatched nucleotides at least 50 times more efficiently than matched nucleotides2. Steady-state kinetic assays determined the apparent binding constants (KM) for APE1 to be similar for mismatched and matched DNA substrates, with the increased efficiency of mismatch removal attributed to a higher rate of catalysis12. To gain insight into substrate specificity of APE1 exo activity between 3′ mismatched and matched DNA, we determined the structure of APE1 bound to a double stranded DNA substrate containing a C/G match at the 3′ end and a phosphate at the 5′ end of a nick (2.6 Å, Table 1). In this structure, Watson–Crick base pairing is retained between C and G at the 3′ end of the nick (Fig. 4b), unlike what was observed in the mismatched C/T structure. The stable C/G base pairing prevents the phosphate backbone from entering the proper registry for cleavage by the APE1 active site (Fig. 4c). An overlay of the C/G and C/T APE1 exo structures, Fig. 4d, reveals the matched C is shifted 7.5 Å downstream and away from the key catalytic residues for exo cleavage. APE1 likely removes a matched base using the same mechanism as a mismatched base, just with a lower efficiency due to the relative lack of flexibility at the 3′ end of the nick, as demonstrated by stable base pairing and low B-factor (36.21 Å2) for C in our C/G structure. This result is in agreement with previous studies showing that the efficiency of the APE1 exo reaction is directly correlated to the thermal stability of its duplex DNA substrate as dictated by the 3′-terminal base pair (with a match being the most stable and having the weakest activity)17.
APE1 poised to remove oxidative DNA damage at the 3′ end
The APE1 exo activity is also involved in the cleaning of DNA “dirty ends”, including DNA damage generated by reactive oxygen species (ROS) during oxidative stress. ROS-induced DNA damage is both a major driver of human disease and a product of environmental exposure, radiation, and chemotherapeutic cancer treatments24,25. One common 3′ damaged terminal end generated by ROS is phosphoglycolate (3′-PG, Fig. 5a). This stable end product blocks replication and repair, and it must be removed prior to further synthesis by a DNA polymerase. While multiple enzymes are capable of removing 3′-PG ends, APE1 has been shown to be the major enzyme responsible for this activity26–29. In the context of BER, APE1 is capable of processing PG at the 3′ end of a nick to produce a 1-nt gapped DNA substrate with a 3′-OH suitable for pol β gap filling DNA synthesis. To gain insight into how APE1 processes damaged DNA ends, we determined the crystal structure of APE1 bound to a double stranded, nicked DNA substrate containing a PG at the 3′ end and a phosphate at the 5′ end of the nick (2.3 Å, Table 1). In this structure, APE1 binds 3′-PG in two alternate conformations, both situating the cleavage site phosphate group in a similar position to what we observed for a 3′ mismatched base (Fig. 5b). However, in the absence of an intact nucleobase at the 3′ end, several waters are observed in the more spacious active site poised to coordinate both ends of the 3′-PG/nicked DNA substrate (Fig. 5c). One water is in position to coordinate both of the PG carbonyl oxygens, at 2.6 and 3.0 Å. Both the cleavage site phosphate and the nucleophilic water are positioned and coordinated almost identically as shown in the mismatched exo substrate structures (Fig. 5d). This is consistent with a universal APE1 3′ to 5′ exo cleavage mechanism among the diverse substrates of PG and a mismatched base.
Further characterization of the APE1 exonuclease reaction
Our structures demonstrate important distinctions between the incision reactions of APE1 during AP-endo and exo functions, suggesting the recognition and repair chemistry of APE1 may be different for these two types of substrates. To probe the APE1 exo mechanism, we conducted pre-steady-state kinetic measurements of APE1 removing a mismatched C, opposite T, at the 3′ end of a centrally located nick in duplex DNA. We utilized a C/T mismatched substrate for characterization of the APE1 exo mechanism because this experimental approach (C nucleobase removal) allows for clearer separation between substrate and product bands on a gel compared to removal of the smaller 3′-PG end damage. Also, the PG and the mismatched C are in an identical location for the APE1 exo activity (Fig. 5d). Kinetic time courses for wild-type APE1 with an exo substrate are compared to those previously obtained with a double stranded DNA AP-endo substrate containing a centrally located AP-site analog (tetrahydrofuran, THF)11. We obtained biphasic time courses of product formation for the exo substrate, demonstrating that catalysis during the first enzymatic turnover (burst phase) is more rapid than in the subsequent steady-state phase where a step after chemistry (likely product release) is rate limiting (Fig. 6a and Table 2)30. For WT-APE1 with a C/T mismatched exo substrate, the observed rate constant of the burst phase was 0.9 ± 0.2 s−1. With this analysis, the burst amplitude represents the apparent active enzyme concentration (26 ± 2 nM) so that the steady-state (kss = vss/[APE1active]) was 0.045 ± 0.008 s−1. Comparing these rates obtained for WT-APE1 with the exo substrate to those with an AP-endo substrate demonstrate that the burst rate and steady-state rates for the APE1-endo reaction are only ~40 and ~18-fold faster than those for the APE1 exo reaction, respectively.
Table 2.
APE1 Variant | [APE1]active (nM) | kobs (s−1) | kss (s−1) |
---|---|---|---|
3′ mismatch (exo) | |||
WT | 26 ± 2 | 0.9 ± 0.2 | 0.045 ± 0.008 |
F266A | 25 ± 5 | 21 ± 7 | 2.1 ± 0.7 |
M270A | 22 ± 4 | 1.9 ± 0.9 | 0.13 ± 0.03 |
R177A | 13 ± 1 | 1.0 ± 0.2 | 0.14 ± 0.01 |
W280A | 17 ± 4 | 0.5 ± 0.2 | 0.21 ± 0.05 |
THF (endo) | |||
WTa | 11 | 36 ± 6 | 0.8 ± 0.1 |
a Freudenthal, B. D. et al.11
To probe the role of several active site residues (M270, R177, W280, and F266), we performed pre-steady-state kinetic measurements on the same nicked 3′ C/T mismatched substrate used above with APE1 variant enzymes (Fig. 6a, b and Table 2). Our APE1 exo structures show M270 wedged between the mismatched bases, leading us to propose that it may play a role destabilizing the base pairing interactions. However, when this residue was mutated to an alanine both the observed burst rate and the steady-state rate were moderately increased compared to wild-type APE1, at 1.9 ± 0.9 s−1 and 0.13 ± 0.03 s−1 respectively, leaving the role of M270 in the exonuclease reaction ambiguous. R177, which has been proposed to facilitate slow product release in the APE1 AP-endo reaction by interacting with the orphan base, was displaced and/or disordered in our exo structures. In agreement with R177 having a neutral role in the exo reaction, kinetic characterization of the R177A APE1 mutant produced an observed burst rate similar to wild type of 1.0 ± 0.2 s−1 and a slightly increased kss of 0.14 ± 0.01 s−1. Our structures indicate that the side chains of both W280 and F266 reduce the size of the APE1 active site, and previous steady-state kinetic analyses indicate W280A and F266A APE1 mutants increase the exo catalytic rate31. In agreement, W280A APE1 showed a ~fivefold increase in the steady-state rate (kss = 0.21 ± 0.05 s−1) compared to wild type. However, there was also a ~twofold decrease in the observed burst rate (kobs = 0.5 ± 0.2 s−1). This indicates that W280 may play a role in the slow product release step of the exo reaction, while also having a modest impact on the incision step.
The F266A APE1 mutation had the most dramatic effect on exo activity, with a ~20-fold increase in the observed burst rate and a ~50-fold increase in the steady-state rate at 21 ± 7 s−1 and 2.1 ± 0.7 s−1, respectively (Fig. 6b and Table 2). Notably, this burst rate is close to what we observed for the APE1 AP-endo reaction (<2-fold difference) and the steady-state rate exceeds that observed for the AP-endo reaction by ~threefold (Table 2). Interestingly, F266A does not have the same effect on the AP-endo reaction32,33. To further elucidate the catalytic role of F266 in the exo reaction, we obtained a 2.0 Å substrate complex structure of F266A APE1 bound to DNA containing a C/T mismatch at the 3′ end of a nick and a PS linkage modification 5′ to the C (Table 1). The structure revealed that mutating F266 to an alanine expands the size of the APE1 active site, allowing the mismatched C to occupy an alternate conformation (Fig. 6c). When the mismatched C and F266 in the WT-APE1 structure are overlaid with those in the F266A APE1 structure, it is revealed that the mismatched C has rotated by ~120° in the mutant structure into a part of the active site that is normally occupied by the F266 side chain (Fig. 6d).
Discussion
The biological significance of APE1 is highlighted by embryonic lethality in mice where its expression is knocked out, expression of inactive variants enhancing cellular sensitivity to DNA damaging therapeutics, and polymorphisms associated with an increased cancer risk34–36. How a single APE1 active site can have various biological activities on an array of nucleic acid substrates has been of interest to researchers for decades2,8,11,26,37–39. A key aspect of the APE1 AP-endo reaction is the flipping of the AP-site into the active site during cleavage. Our structures demonstrate APE1 uses the same active site to exonucleically remove 3′ mismatches and DNA damage by a non-base flipping mechanism. Instead, key mechanistic features include the 3′ end of a DNA nick sliding into the APE1 active site where it is stabilized by protein contacts, the instability of the 3′ end resulting from the mismatch/damage, and DNA bending9,14–16. Also, several residues are positioned to interact with the 5′ phosphate, providing an explanation for differences in incision efficiency based on the nature of the 5′ terminal group9,17. These DNA-centric mechanistic features are present in cases of other 3′ bulky end damages and nucleotide analogs, indicating the mechanism could be universal for APE1 exo function40. Importantly, our structures show that the APE1 active site is quite rigid and incision differences between substrates likely results from altered DNA conformations, as opposed to APE1 conformational changes12.
The relatively weak exo activity of APE1 in comparison to its AP-endo function has been primarily attributed to a hindered catalytic reaction (kcat)9,41. Our kinetics show that rates for both the chemistry step and the product release step of the exo reaction on a mismatch are reduced in comparison to the AP-endo reaction by only ~40-fold and ~18-fold, respectively. This reduction in rate is recovered by the single F266A mutation, which increases space in the APE1 active site and allows the mismatched base to adopt an alternative conformation (Fig. 6, Table 2). A restrictive active site and larger exo substrate may be responsible for the reduced incision rate for the APE1 exo reaction. The hydrophobic pocket, comprised of F266 and W280, is not well conserved and appears to play a role in substrate specificity between ExoIII family members31. To this point, Escherichia coli ExoIII possesses a hydrophobic pocket composed of only one aromatic residue, and exhibits a relatively strong 3′ to 5′ exonuclease activity. Similarly, members of the APE2 subfamily completely lack this hydrophobic pocket and have a strong preference for exo substrates compared to AP-endo substrates31,42–44.
At estimated in vivo APE1 protein concentrations, the exo activity of APE1 is rather robust in vitro, and thus is presumably regulated by additional cellular factors and/or is directed to its preferred substrates9,45. Our structures demonstrate that flexibility at the 3′ end (from a mismatch or DNA damage) confers at least some specificity, supporting a biological role for APE1 exo activity in proofreading misinsertions and removal of 3′ dirty ends during BER to generate suitable substrates for downstream repair enzymes. The BER ligation reaction has a demonstrated dependence on the presence of APE1 in reconstituted BER systems2. Moreover, the lower efficiency of DNA ligase in rejoining mispaired DNA creates a window of time for APE1 to remove the mismatched nucleotide. Although other 3′ to 5′ DNA exonucleases have been proposed to potentially provide a proofreading function for DNA pol β, APE1 is conceptually more suitable for this task as its physical interaction with DNA pol β has already been shown46–48.
It is of interest to consider whether or not the APE1 exo mechanism could be used to perform other DNA cleavage reactions attributed to APE1. For example, APE1 performs backbone cleavage during the nucleotide incision repair (NIR) pathway49,50. APE1 NIR activity consists of incision at the 5′ side of a damaged base in a DNA glycosylase-independent manner, followed by the subsequent repair through downstream factors14,51–53. Interestingly, the optimal conditions for NIR activity are very similar to those required for the APE1 exo activity, and differ from those for the AP-endo activity49. Furthermore, a role is emerging for APE1 endoribonuclease cleavage in the post-translational regulation of RNAs, such as c-myc37,54–56. As these substrates would require considerable active site real-estate, APE1 likely uses an intra-helical exo-like mechanism during NIR and RNA cleavage. The structures presented here provide valuable insight into how APE1 utilizes the same active site to cleave small AP-sites and bulkier substrates, including the proofreading of mismatches and the cleaning-up of DNA damage that blocks DNA replication and repair.
Methods
DNA sequences
To generate the 21-mer nicked duplex for crystallization, the following DNA sequences were used: matched opposing strand, 5′-GGA-TCC-GTC-GAG-CGC-ATC-AGC-3′; mismatched opposing strand, 5′-GGA-TCC-GTC-GAT-CGC-ATC-AGC-3′; upstream strand with 3′ cytosine, 5′-GCT-GAT-GCG-C-3′; upsteam stand with 3′-PG, 5′-GCT-GAT-GCG-(PG)-3′; downstream strand with a 5′-phosphate, 5′-TCG-ACG-GAT-CC-3′. To generate the 30-mer for the kinetic studies the following DNA sequences were used: matched opposing strand, 5′- ATG-CGG-ATC-CGT-CGA-GCG-CAT-CAG-CGA-ACG-3′; mismatched opposing strand, 5′-ATG-CGG-ATC-CGT-CGA-TCG-CAT-CAG-CGA-ACG-3′; upstream strand with a fluorescein (indicated by astrick), 5′-*CGT-TCG-CTG-ATG-CGC-3′; downstream strand with a 5′-phosphate, 5′-TCG-ACG-GAT-CCG-CAT-3′. All sequences were purchased from IDT, except for the PG containing sequence which was purchased from Eurogentec. The oligonucleotides were separated from other DNA species by electrophoresis on a 16% polyacrylamide gel containing 7 M urea in TBE buffer. Purified DNA substrates were annealed in buffer containing 50 mM tris and 50 mM KCl, and the concentration was determined by absorbance at 260 nm.
Protein expression and purification
Human wild-type and truncated APE1 (lacking 43 N-terminal amino acids, ΔAPE1) were expressed from pet28a codon optimized clones purchased from GeneScript. All mutagenesis was carried out in either the full-length or truncated clones using QuikChange II site-directed mutagenesis (Agilent) and the primer sequences are shown in Supplementary Table 1. APE1 was expressed in One Shot BL21(DE3)plysS E. coli cells (Invitrogen), grown at 37 °C until induced at OD = 0.6, and then grown overnight at 20 °C. After harvesting, cells were lysed at 4 °C by sonication in 50 mM HEPES, pH 7.4, 50 mM NaCl, and a protease inhibitor cocktail. The lysate was pelleted at 24,242 × g for 1 h. The resulting supernatant was passed over a HiTrap Heparin HP (GE Health Sciences) equilibrated with lysate buffer. APE1 was eluting from the heparin column with a linear gradient of NaCl up to 1 M. APE1 eluting at high salt was buffer exchanged into 50 mM NaCl and loaded onto a POROS HS cation exchange column (GE Health Sciences) and eluted with a linear gradient of NaCl up to 1 M. Purified APE1 was subsequently loaded onto a HiPrep 16/60 Sephacryl S-200 HR (GE Health Sciences). The resulting pure fractions were concentrated and stored at −80 °C. Final concentrations was determined by NanoDrop One UV–Vis Spectrophotometer (Thermo Scientific).
Crystallization and structure determination
DNA substrates for APE1–DNA complex crystals were made by annealing 2 mM of three oligonucleotides in a 1:1:1 ratio to form a 21-mer duplex with a central nick using a PCR thermocycler by heating for 10 min at 90 °C and cooling to 4 °C (1 °C min−1). The annealed DNA was mixed with truncated C138A-APE1 to achieve a final concentration of 0.56 mM DNA and 10–12 mg ml−1 C138A-APE1. The single amino acid C138A mutation and truncation of the N-terminal 40 amino acids aid in crystallization23. APE1-DNA complexes were crystalized by vapor diffusion. The reservoir solution for crystal formation was 7–14% PEG 20 K, 100 mM sodium citrate, pH 5.0, 15% glycerol, and 5 mM CaCl2. Crystals grew within a week at 20 °C. APE1-DNA crystals were transferred to a cryosolution containing the mother liquor with 20% ethylene glycol. Data were collected at 100 K on a Rigaku MicroMax-007 HF rotating anode diffractometer equipped with a Dectris Pilatus3R 200K-A detector system at a wavelength of 1.54 Å. This allowed for anomalous data detection after phasing by molecular replacement with high redundancy. Data were processed and scaled with the HKL3000R software package57. Initial models were determined by molecular replacement with a modified version of a previously determined APE1–DNA complex (PDB 5DFF) as a reference. Refinement was carried out with PHENIX and model building with Coot58,59. The PS linkage containing substrates are present in two isomers, Sp and Rp. In our crystal structures, we observed both isomers in the active site with equal occupancy (Supplementary Fig. 1). The figures were prepared with PyMOL (Schrödinger LLC), and for simplicity only one conformation is shown for residues with alternate conformations unless otherwise noted.
Kinetic characterization
A rapid quench-flow instrument (KinTek RQF-3) was used for enzyme activity measurements. DNA substrates used to measure APE1 incision activity (37 °C) contained a 5′,6-carboxyfluorescein (6-FAM) label and were designed with a centrally located nick flanked by a 3′ mismatched cytosine and a 5′-phosphate. The reaction buffer was 50 mM HEPES, pH 7.4, 100 mM KCl, 3 mM MgCl2, and 0.1 mg ml−1 BSA. Final concentrations were 100 nM DNA substrate and 30 nM APE1 after mixing. At indicated time intervals, aliquots were quenched by mixing with 100 mM EDTA. An equal volume of DNA gel loading buffer (100 mM EDTA, 80% deionized formamide, 0.25 mg ml−1 bromophenol blue and 0.25 mg ml−1 xylene cyanol) was added to the quenched reaction mixture. After incubation at 95 °C for 5 min, the reaction products were separated by 16% denaturing polyacrylamide gel. All time points are the mean of three independent experiments. A GE Typhoon FLA 9500 imager in fluorescence mode was used for gel scanning and imaging, and the data were analyzed with Image J software60. The biphasic time courses were fit to the equation: Product = A(1−e−kobst) + vsst, where A represents the amplitude of the rising exponential and kobs the first order rate constant. The steady-state rate constant (kss) is the steady-state velocity (vss) A−1, where A represents the fraction of actively bound enzyme.
Data availability
Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 5WN4, 5WN5, 5WN1, 5WN0, 5WN2, and 5WN3. Other data are available from the corresponding author upon reasonable request.
Electronic supplementary material
Acknowledgements
Funding for this work was provided by National Institutes of Environmental Health Sciences of the National Institutes of Health grant R00ES024431.
Author contributions
A.M.W. and B.D.F. designed the project. A.M.W. and T.S.F. carried out crystallography. A.M.W. did the kinetic analyses. A.M.W. and B.D.F. prepared the manuscript. All authors discussed the results and commented on the manuscript.
Competing interests
The authors declare no competing financial interests.
Footnotes
Electronic supplementary material
Supplementary Information accompanies this paper at 10.1038/s41467-017-02175-y.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Whitaker AM, Schaich MA, Smith MS, Flynn TS, Freudenthal BD. Base excision repair of oxidative DNA damage: from mechanism to disease. Front. Biosci. (Landmark Ed.) 2017;22:1493–1522. doi: 10.2741/4555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chou KM, Cheng YC. An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3´ mispaired DNA. Nature. 2002;415:655–659. doi: 10.1038/415655a. [DOI] [PubMed] [Google Scholar]
- 3.Wong D, DeMott MS, Demple B. Modulation of the 3′—>5′-exonuclease activity of human apurinic endonuclease (Ape1) by its 5′-incised Abasic DNA product. J. Biol. Chem. 2003;278:36242–36249. doi: 10.1074/jbc.M306065200. [DOI] [PubMed] [Google Scholar]
- 4.Andres SN, Schellenberg MJ, Wallace BD, Tumbale P, Williams RS. Recognition and repair of chemically heterogeneous structures at DNA ends. Environ. Mol. Mutagen. 2015;56:1–21. doi: 10.1002/em.21892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bambara RA, Jessee CB. Properties of DNA polymerases delta and epsilon, and their roles in eukaryotic DNA replication. Biochim. Biophys. Acta. 1991;1088:11–24. doi: 10.1016/0167-4781(91)90147-E. [DOI] [PubMed] [Google Scholar]
- 6.Osheroff WP, Jung HK, Beard WA, Wilson SH, Kunkel TA. The fidelity of DNA polymerase beta during distributive and processive DNA synthesis. J. Biol. Chem. 1999;274:3642–3650. doi: 10.1074/jbc.274.6.3642. [DOI] [PubMed] [Google Scholar]
- 7.Freudenthal BD, et al. Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide. Nature. 2015;517:635–639. doi: 10.1038/nature13886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Caglayan M, Horton JK, Dai DP, Stefanick DF, Wilson SH. Oxidized nucleotide insertion by pol beta confounds ligation during base excision repair. Nat. Commun. 2017;8:14045. doi: 10.1038/ncomms14045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wilson DM3rd. Properties of and substrate determinants for the exonuclease activity of human apurinic endonuclease Ape1. J. Mol. Biol. 2003;330:1027–1037. doi: 10.1016/S0022-2836(03)00712-5. [DOI] [PubMed] [Google Scholar]
- 10.Mol CD, Izumi T, Mitra S, Tainer JA. DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination [corrected] Nature. 2000;403:451–456. doi: 10.1038/35000249. [DOI] [PubMed] [Google Scholar]
- 11.Freudenthal BD, Beard WA, Cuneo MJ, Dyrkheeva NS, Wilson SH. Capturing snapshots of APE1 processing DNA damage. Nat. Struct. Mol. Biol. 2015;22:924–931. doi: 10.1038/nsmb.3105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chou KM, Cheng YC. The exonuclease activity of human apurinic/apyrimidinic endonuclease (APE1). Biochemical properties and inhibition by the natural dinucleotide Gp4G. J. Biol. Chem. 2003;278:18289–18296. doi: 10.1074/jbc.M212143200. [DOI] [PubMed] [Google Scholar]
- 13.Poletto, M., Lirussi, L., Antoniali, G. & Tell, G. in The Base Excision Repair Pathway (ed Wilson, D. M. 3rd) Ch. 5, 219-251 (World Scientific, 2017).
- 14.Aboul-ela F, Koh D, Tinoco I, Jr, Martin FH. Base-base mismatches. Thermodynamics of double helix formation for dCA3XA3G+dCT3YT3G (X, Y = A,C,G,T) Nucleic Acids Res. 1985;13:4811–4824. doi: 10.1093/nar/13.13.4811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Allawi HT, SantaLucia J., Jr Thermodynamics of internal C.T mismatches in DNA. Nucleic Acids Res. 1998;26:2694–2701. doi: 10.1093/nar/26.11.2694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.SantaLucia J, Jr, Hicks D. The thermodynamics of DNA structural motifs. Annu. Rev. Biophys. Biomol. Struct. 2004;33:415–440. doi: 10.1146/annurev.biophys.32.110601.141800. [DOI] [PubMed] [Google Scholar]
- 17.Dyrkheeva NS, Lomzov AA, Pyshnyi DV, Khodyreva SN, Lavrik OI. Efficiency of exonucleolytic action of apurinic/apyrimidinic endonuclease 1 towards matched and mismatched dNMP at the 3′ terminus of different oligomeric DNA structures correlates with thermal stability of DNA duplexes. Biochim. Biophys. Acta. 2006;1764:699–706. doi: 10.1016/j.bbapap.2006.01.004. [DOI] [PubMed] [Google Scholar]
- 18.Barzilay G, et al. Identification of critical active-site residues in the multifunctional human DNA repair enzyme HAP1. Nat. Struct. Biol. 1995;2:561–568. doi: 10.1038/nsb0795-561. [DOI] [PubMed] [Google Scholar]
- 19.Miroshnikova AD, Kuznetsova AA, Vorobjev YN, Kuznetsov NA, Fedorova OS. Effects of mono- and divalent metal ions on DNA binding and catalysis of human apurinic/apyrimidinic endonuclease 1. Mol. Biosyst. 2016;12:1527–1539. doi: 10.1039/C6MB00128A. [DOI] [PubMed] [Google Scholar]
- 20.Wilson DM3rd, Takeshita M, Grollman AP, Demple B. Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J. Biol. Chem. 1995;270:16002–16007. doi: 10.1074/jbc.270.27.16002. [DOI] [PubMed] [Google Scholar]
- 21.Mundle ST, Delaney JC, Essigmann JM, Strauss PR. Enzymatic mechanism of human apurinic/apyrimidinic endonuclease against a THF AP site model substrate. Biochemistry. 2009;48:19–26. doi: 10.1021/bi8016137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lipton AS, et al. Characterization of Mg2+ binding to the DNA repair protein apurinic/apyrimidic endonuclease 1 via solid-state 25Mg NMR spectroscopy. J. Am. Chem. Soc. 2008;130:9332–9341. doi: 10.1021/ja0776881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.He H, Chen Q, Georgiadis MM. High-resolution crystal structures reveal plasticity in the metal binding site of apurinic/apyrimidinic endonuclease I. Biochemistry. 2014;53:6520–6529. doi: 10.1021/bi500676p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Brieger K, Schiavone S, Miller FJ, Jr, Krause KH. Reactive oxygen species: from health to disease. Swiss Med. Wkly. 2012;142:w13659. doi: 10.4414/smw.2012.13659. [DOI] [PubMed] [Google Scholar]
- 25.Shacter E, Williams JA, Hinson RM, Senturker S, Lee YJ. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood. 2000;96:307–313. [PubMed] [Google Scholar]
- 26.Parsons JL, Dianova II, Dianov GL. APE1 is the major 3′-phosphoglycolate activity in human cell extracts. Nucleic Acids Res. 2004;32:3531–3536. doi: 10.1093/nar/gkh676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Suh D, Wilson DM3rd, Povirk LF. 3′-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res. 1997;25:2495–2500. doi: 10.1093/nar/25.12.2495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Winters TA, Henner WD, Russell PS, McCullough A, Jorgensen TJ. Removal of 3′-phosphoglycolate from DNA strand-break damage in an oligonucleotide substrate by recombinant human apurinic/apyrimidinic endonuclease 1. Nucleic Acids Res. 1994;22:1866–1873. doi: 10.1093/nar/22.10.1866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Zhou T, et al. Tyrosyl-DNA phosphodiesterase and the repair of 3′-phosphoglycolate-terminated DNA double-strand breaks. DNA Repair (Amst.) 2009;8:901–911. doi: 10.1016/j.dnarep.2009.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Maher RL, Bloom LB. Pre-steady-state kinetic characterization of the AP endonuclease activity of human AP endonuclease 1. J. Biol. Chem. 2007;282:30577–30585. doi: 10.1074/jbc.M704341200. [DOI] [PubMed] [Google Scholar]
- 31.Hadi MZ, Ginalski K, Nguyen LH, Wilson DM3rd. Determinants in nuclease specificity of Ape1 and Ape2, human homologues of Escherichia coli exonuclease III. J. Mol. Biol. 2002;316:853–866. doi: 10.1006/jmbi.2001.5382. [DOI] [PubMed] [Google Scholar]
- 32.Kim WC, et al. Characterization of the endoribonuclease active site of human apurinic/apyrimidinic endonuclease 1. J. Mol. Biol. 2011;411:960–971. doi: 10.1016/j.jmb.2011.06.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Erzberger JP, Barsky D, Scharer OD, Colvin ME, Wilson DM3rd. Elements in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic endonucleases. Nucleic Acids Res. 1998;26:2771–2778. doi: 10.1093/nar/26.11.2771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ludwig DL, et al. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 1998;409:17–29. doi: 10.1016/S0921-8777(98)00039-1. [DOI] [PubMed] [Google Scholar]
- 35.Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl Acad. Sci. USA. 1996;93:8919–8923. doi: 10.1073/pnas.93.17.8919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.McNeill DR, Lam W, DeWeese TL, Cheng YC, Wilson DM3rd. Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites. Mol. Cancer Res. 2009;7:897–906. doi: 10.1158/1541-7786.MCR-08-0519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Antoniali, G., Malfatti, M. C. & Tell, G. Unveiling the non-repair face of the base excision repair pathway in RNA processing: a missing link between DNA repair and gene expression? DNA Repair (Amst.) 56 65–74 (2017). [DOI] [PubMed]
- 38.Parsons JL, Dianova II, Dianov GL. APE1-dependent repair of DNA single-strand breaks containing 3′-end 8-oxoguanine. Nucleic Acids Res. 2005;33:2204–2209. doi: 10.1093/nar/gki518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chou KM, Kukhanova M, Cheng YC. A novel action of human apurinic/apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3′ termini of DNA. J. Biol. Chem. 2000;275:31009–31015. doi: 10.1074/jbc.M004082200. [DOI] [PubMed] [Google Scholar]
- 40.Mazouzi A, et al. Insight into mechanisms of 3′-5′ exonuclease activity and removal of bulky 8,5′-cyclopurine adducts by apurinic/apyrimidinic endonucleases. Proc. Natl Acad. Sci. USA. 2013;110:E3071–E3080. doi: 10.1073/pnas.1305281110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Masuda Y, Bennett RAO, Demple B. Dynamics of the interaction of human apurinic endonuclease (Ape1) with Its substrate and product. J. Biol. Chem. 1998;273:30352–30359. doi: 10.1074/jbc.273.46.30352. [DOI] [PubMed] [Google Scholar]
- 42.Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 1994;63:915–948. doi: 10.1146/annurev.bi.63.070194.004411. [DOI] [PubMed] [Google Scholar]
- 43.Wallace BD, et al. APE2 Zf-GRF facilitates 3′-5′ resection of DNA damage following oxidative stress. Proc. Natl Acad. Sci. USA. 2017;114:304–309. doi: 10.1073/pnas.1610011114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Willis J, Patel Y, Lentz BL, Yan S. APE2 is required for ATR-Chk1 checkpoint activation in response to oxidative stress. Proc. Natl Acad. Sci. USA. 2013;110:10592–10597. doi: 10.1073/pnas.1301445110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cappelli E, et al. Rates of base excision repair are not solely dependent on levels of initiating enzymes. Carcinogenesis. 2001;22:387–393. doi: 10.1093/carcin/22.3.387. [DOI] [PubMed] [Google Scholar]
- 46.Bennett RA, Wilson DM3rd, Wong D, Demple B. Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc. Natl Acad. Sci. USA. 1997;94:7166–7169. doi: 10.1073/pnas.94.14.7166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Moor NA, Vasil’eva IA, Anarbaev RO, Antson AA, Lavrik OI. Quantitative characterization of protein-protein complexes involved in base excision DNA repair. Nucleic Acids Res. 2015;43:6009–6022. doi: 10.1093/nar/gkv569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Prasad R, Shock DD, Beard WA, Wilson SH. Substrate channeling in mammalian base excision repair pathways: passing the baton. J. Biol. Chem. 2010;285:40479–40488. doi: 10.1074/jbc.M110.155267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Gros L, Ishchenko AA, Ide H, Elder RH, Saparbaev MK. The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway. Nucleic Acids Res. 2004;32:73–81. doi: 10.1093/nar/gkh165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ishchenko AA, et al. Uncoupling of the base excision and nucleotide incision repair pathways reveals their respective biological roles. Proc. Natl Acad. Sci. USA. 2006;103:2564–2569. doi: 10.1073/pnas.0508582103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kim K, Biade S, Matsumoto Y. Involvement of flap endonuclease 1 in base excision DNA repair. J. Biol. Chem. 1998;273:8842–8848. doi: 10.1074/jbc.273.15.8842. [DOI] [PubMed] [Google Scholar]
- 52.Klungland A, Lindahl T. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1) EMBO J. 1997;16:3341–3348. doi: 10.1093/emboj/16.11.3341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Hang B, Rothwell DG, Sagi J, Hickson ID, Singer B. Evidence for a common active site for cleavage of an AP site and the benzene-derived exocyclic adduct, 3,N4-benzetheno-dC, in the major human AP endonuclease. Biochemistry. 1997;36:15411–15418. doi: 10.1021/bi971367s. [DOI] [PubMed] [Google Scholar]
- 54.Tell G, Wilson DM3rd, Lee CH. Intrusion of a DNA repair protein in the RNome world: is this the beginning of a new era? Mol. Cell. Biol. 2010;30:366–371. doi: 10.1128/MCB.01174-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Vohhodina J, Harkin DP, Savage KI. Dual roles of DNA repair enzymes in RNA biology/post-transcriptional control. Wiley Interdiscip. Rev. RNA. 2016;7:604–619. doi: 10.1002/wrna.1353. [DOI] [PubMed] [Google Scholar]
- 56.Barnes T, et al. Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA. Nucleic Acids Res. 2009;37:3946–3958. doi: 10.1093/nar/gkp275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- 58.Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- 60.Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 5WN4, 5WN5, 5WN1, 5WN0, 5WN2, and 5WN3. Other data are available from the corresponding author upon reasonable request.